 Mark Zabel
Concepts (146)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Wasting Disease, Chronic | 9 | 2019 | 36 | 2.340 |
Why?
| | Prions | 9 | 2022 | 59 | 2.330 |
Why?
| | Prion Diseases | 6 | 2022 | 21 | 1.620 |
Why?
| | Defibrillators, Implantable | 6 | 2026 | 387 | 1.500 |
Why?
| | Deer | 8 | 2019 | 43 | 1.190 |
Why?
| | Death, Sudden, Cardiac | 6 | 2026 | 237 | 1.070 |
Why?
| | Blood-Brain Barrier | 3 | 2019 | 160 | 0.910 |
Why?
| | Liposomes | 3 | 2019 | 263 | 0.810 |
Why?
| | RNA, Small Interfering | 3 | 2019 | 638 | 0.790 |
Why?
| | Immune System | 2 | 2012 | 180 | 0.620 |
Why?
| | Lipopeptides | 1 | 2019 | 17 | 0.580 |
Why?
| | Comparative Effectiveness Research | 1 | 2019 | 169 | 0.550 |
Why?
| | Dendritic Cells | 3 | 2017 | 500 | 0.540 |
Why?
| | Gene Transfer Techniques | 1 | 2019 | 187 | 0.510 |
Why?
| | Complement Factor H | 1 | 2017 | 79 | 0.490 |
Why?
| | Animal Feed | 1 | 2016 | 49 | 0.470 |
Why?
| | Neurons | 3 | 2019 | 1652 | 0.470 |
Why?
| | B-Lymphocytes | 3 | 2017 | 872 | 0.470 |
Why?
| | PrPC Proteins | 2 | 2017 | 8 | 0.460 |
Why?
| | Magnesium | 1 | 2016 | 157 | 0.460 |
Why?
| | Soil | 2 | 2016 | 147 | 0.450 |
Why?
| | Complement C3 | 2 | 2013 | 187 | 0.450 |
Why?
| | Copper | 1 | 2016 | 120 | 0.450 |
Why?
| | Primary Prevention | 4 | 2026 | 222 | 0.420 |
Why?
| | Central Nervous System | 1 | 2016 | 282 | 0.410 |
Why?
| | Macrophages | 3 | 2017 | 1507 | 0.400 |
Why?
| | Bentonite | 1 | 2013 | 2 | 0.390 |
Why?
| | Drug Delivery Systems | 1 | 2016 | 381 | 0.370 |
Why?
| | Receptors, Complement 3b | 1 | 2012 | 77 | 0.370 |
Why?
| | Brain | 5 | 2017 | 2969 | 0.370 |
Why?
| | PrPSc Proteins | 1 | 2012 | 9 | 0.360 |
Why?
| | Receptors, Complement | 1 | 2012 | 123 | 0.350 |
Why?
| | Receptors, Complement 3d | 1 | 2012 | 129 | 0.350 |
Why?
| | Monitoring, Immunologic | 1 | 2010 | 25 | 0.330 |
Why?
| | Electrocardiography | 4 | 2022 | 668 | 0.330 |
Why?
| | Lymph Nodes | 2 | 2012 | 509 | 0.310 |
Why?
| | Feces | 2 | 2012 | 496 | 0.300 |
Why?
| | Brain Diseases | 1 | 2010 | 155 | 0.290 |
Why?
| | Mice | 12 | 2019 | 18357 | 0.290 |
Why?
| | Europe | 2 | 2020 | 421 | 0.290 |
Why?
| | Animals | 17 | 2019 | 38100 | 0.280 |
Why?
| | Cations | 2 | 2019 | 83 | 0.260 |
Why?
| | Mice, Knockout | 5 | 2017 | 3130 | 0.260 |
Why?
| | Mice, Transgenic | 6 | 2016 | 2191 | 0.240 |
Why?
| | Inflammation | 2 | 2022 | 2883 | 0.230 |
Why?
| | Saliva | 2 | 2023 | 249 | 0.230 |
Why?
| | Immunohistochemistry | 4 | 2013 | 1723 | 0.220 |
Why?
| | Blotting, Western | 4 | 2013 | 1184 | 0.190 |
Why?
| | Ventricular Function, Left | 3 | 2020 | 544 | 0.180 |
Why?
| | Biological Assay | 3 | 2013 | 132 | 0.180 |
Why?
| | Animals, Wild | 2 | 2012 | 62 | 0.180 |
Why?
| | Prion Proteins | 2 | 2022 | 7 | 0.170 |
Why?
| | Stroke Volume | 2 | 2020 | 655 | 0.160 |
Why?
| | Polymerase Chain Reaction | 1 | 2023 | 1043 | 0.150 |
Why?
| | Electroshock | 1 | 2019 | 146 | 0.150 |
Why?
| | Tachycardia | 1 | 2019 | 58 | 0.150 |
Why?
| | Prospective Studies | 3 | 2022 | 8075 | 0.150 |
Why?
| | Observational Studies as Topic | 1 | 2019 | 134 | 0.140 |
Why?
| | RNA, Viral | 1 | 2023 | 692 | 0.140 |
Why?
| | Myocardial Infarction | 1 | 2026 | 1211 | 0.140 |
Why?
| | Cardiac Electrophysiology | 1 | 2018 | 22 | 0.140 |
Why?
| | Equipment and Supplies | 1 | 2018 | 37 | 0.140 |
Why?
| | Sensitivity and Specificity | 1 | 2023 | 2000 | 0.130 |
Why?
| | Monocytes | 2 | 2012 | 539 | 0.130 |
Why?
| | Multicenter Studies as Topic | 1 | 2019 | 413 | 0.130 |
Why?
| | Flow Cytometry | 2 | 2012 | 1165 | 0.130 |
Why?
| | Autonomic Nervous System | 1 | 2017 | 83 | 0.130 |
Why?
| | Phosphatidylinositols | 1 | 2017 | 58 | 0.130 |
Why?
| | Amyloidosis | 1 | 2017 | 45 | 0.120 |
Why?
| | RNA Interference | 1 | 2019 | 475 | 0.120 |
Why?
| | Phosphatidylethanolamines | 1 | 2017 | 77 | 0.120 |
Why?
| | Cells, Cultured | 2 | 2017 | 4151 | 0.120 |
Why?
| | Complement Inactivating Agents | 1 | 2017 | 74 | 0.120 |
Why?
| | Complement Pathway, Alternative | 1 | 2017 | 121 | 0.120 |
Why?
| | Treatment Outcome | 3 | 2020 | 11793 | 0.120 |
Why?
| | Phosphatidylcholines | 1 | 2017 | 131 | 0.120 |
Why?
| | Amyloid | 1 | 2017 | 96 | 0.120 |
Why?
| | Cardiovascular System | 1 | 2017 | 139 | 0.120 |
Why?
| | Risk Factors | 4 | 2022 | 10916 | 0.110 |
Why?
| | Public Health | 1 | 2019 | 574 | 0.100 |
Why?
| | Mice, Inbred C57BL | 2 | 2017 | 5992 | 0.100 |
Why?
| | Protein Isoforms | 2 | 2012 | 399 | 0.100 |
Why?
| | Lethal Dose 50 | 1 | 2013 | 17 | 0.100 |
Why?
| | Humans | 12 | 2026 | 145750 | 0.100 |
Why?
| | Water | 1 | 2016 | 447 | 0.090 |
Why?
| | Brain Chemistry | 1 | 2013 | 120 | 0.090 |
Why?
| | Adsorption | 1 | 2013 | 153 | 0.090 |
Why?
| | Complement C1q | 1 | 2012 | 32 | 0.090 |
Why?
| | Disease Models, Animal | 2 | 2013 | 4569 | 0.090 |
Why?
| | Gene Knockout Techniques | 1 | 2012 | 119 | 0.090 |
Why?
| | Silicon Dioxide | 1 | 2013 | 119 | 0.090 |
Why?
| | Lymphoid Tissue | 1 | 2012 | 78 | 0.090 |
Why?
| | Protein Binding | 1 | 2017 | 2240 | 0.080 |
Why?
| | Spleen | 1 | 2013 | 508 | 0.080 |
Why?
| | Microscopy, Confocal | 1 | 2012 | 319 | 0.080 |
Why?
| | Diabetes Mellitus | 1 | 2019 | 1101 | 0.080 |
Why?
| | Protein Transport | 1 | 2012 | 442 | 0.080 |
Why?
| | Cohort Studies | 1 | 2020 | 6032 | 0.080 |
Why?
| | Receptors, CCR2 | 1 | 2009 | 39 | 0.070 |
Why?
| | Immunity, Cellular | 1 | 2010 | 274 | 0.070 |
Why?
| | Encephalomyelitis, Autoimmune, Experimental | 1 | 2009 | 69 | 0.070 |
Why?
| | Risk Assessment | 1 | 2018 | 3752 | 0.070 |
Why?
| | Base Sequence | 1 | 2010 | 2171 | 0.060 |
Why?
| | Neutrophils | 1 | 2012 | 1125 | 0.060 |
Why?
| | Amino Acid Sequence | 1 | 2010 | 2131 | 0.060 |
Why?
| | Molecular Sequence Data | 1 | 2010 | 2883 | 0.060 |
Why?
| | Disease Progression | 1 | 2013 | 2865 | 0.060 |
Why?
| | Meta-Analysis as Topic | 1 | 2026 | 173 | 0.060 |
Why?
| | Cell Line | 1 | 2010 | 2823 | 0.050 |
Why?
| | Aged | 2 | 2020 | 26212 | 0.050 |
Why?
| | Colorado | 1 | 2013 | 4556 | 0.050 |
Why?
| | Incidence | 2 | 2019 | 2933 | 0.050 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1997 | 0.050 |
Why?
| | Neuroglia | 1 | 2022 | 174 | 0.040 |
Why?
| | Time Factors | 1 | 2012 | 7133 | 0.040 |
Why?
| | Microglia | 1 | 2022 | 273 | 0.040 |
Why?
| | Research Design | 1 | 2026 | 1139 | 0.040 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2026 | 1751 | 0.040 |
Why?
| | Arrhythmias, Cardiac | 1 | 2022 | 356 | 0.040 |
Why?
| | North America | 1 | 2019 | 303 | 0.030 |
Why?
| | Autonomic Nervous System Diseases | 1 | 2017 | 38 | 0.030 |
Why?
| | Cardiovascular Physiological Phenomena | 1 | 2017 | 49 | 0.030 |
Why?
| | Diabetic Angiopathies | 1 | 2019 | 265 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2022 | 2123 | 0.030 |
Why?
| | Protein Folding | 1 | 2017 | 277 | 0.030 |
Why?
| | Female | 4 | 2020 | 79025 | 0.030 |
Why?
| | Prognosis | 1 | 2022 | 4329 | 0.020 |
Why?
| | Heart Rate | 1 | 2017 | 856 | 0.020 |
Why?
| | Cell Membrane | 1 | 2017 | 709 | 0.020 |
Why?
| | Male | 3 | 2020 | 72992 | 0.020 |
Why?
| | Retrospective Studies | 2 | 2020 | 17322 | 0.020 |
Why?
| | Blood Pressure | 1 | 2017 | 1782 | 0.020 |
Why?
| | Registries | 1 | 2019 | 2410 | 0.020 |
Why?
| | Follow-Up Studies | 1 | 2019 | 5428 | 0.020 |
Why?
| | Chimera | 1 | 2009 | 61 | 0.020 |
Why?
| | Gene Targeting | 1 | 2009 | 81 | 0.020 |
Why?
| | Chemotaxis, Leukocyte | 1 | 2009 | 114 | 0.020 |
Why?
| | Adoptive Transfer | 1 | 2009 | 200 | 0.020 |
Why?
| | Telemedicine | 1 | 2018 | 963 | 0.020 |
Why?
| | Bone Marrow Cells | 1 | 2009 | 322 | 0.020 |
Why?
| | Cell Division | 1 | 2009 | 757 | 0.020 |
Why?
| | Enzyme-Linked Immunosorbent Assay | 1 | 2009 | 849 | 0.020 |
Why?
| | Multiple Sclerosis | 1 | 2009 | 489 | 0.010 |
Why?
| | Autoimmunity | 1 | 2009 | 933 | 0.010 |
Why?
| | Endothelium, Vascular | 1 | 2009 | 956 | 0.010 |
Why?
| | Middle Aged | 1 | 2019 | 36297 | 0.010 |
Why?
|
|
Zabel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
|